Friday, May 14, 2021

hepatitis - symptoms

Many people with hepatitis A, B, C, D or E exhibit only mild symptoms or no symptoms at all. Each form of the virus, however, can cause more severe symptoms. 

Symptoms of hepatitis A, B and C may include fever, malaise, loss of appetite, diarrhoea, nausea, abdominal discomfort, dark-coloured urine and jaundice (a yellowing of the skin and whites of the eyes). 

In some cases, the virus can also cause a chronic liver infection that can later develop into cirrhosis (a scarring of the liver) or liver cancer. These patients are at risk of death.

Hepatitis D (HDV) is only found in people already infected with hepatitis B (HBV); however, the dual infection of HBV and HDV can cause a more serious infection and poorer health outcomes, including accelerated progression to cirrhosis. Development of chronic hepatitis D is rare.

Hepatitis E (HEV) begins with mild fever, reduced appetite, nausea and vomiting lasting for a few days. Some persons may also have abdominal pain, itching (without skin lesions), skin rash or joint pain. They may also exhibit jaundice, with dark urine and pale stools, and a slightly enlarged, tender liver (hepatomegaly), or occasionally acute liver failure.

Related Posts:

  • AgonistsAn agonist is a drug that binds to and activates the receptor site, eliciting a cellular response. Agonist binding may activate a receptor that was re… Read More
  • Inverse AgonistsInverse agonists are drugs that have affinity at the receptor site but produce opposite actions (turn “off” a receptor that is activated or turn … Read More
  • AntagonistsAntagonists bind to the receptor site and do not activate the receptor. They prevent another drug or natural body chemical from binding by occupying o… Read More
  • First Pass EffectOrally administered drugs must pass into the hepatoportal circulation (liver) before entering the general circulation. The first-pass effect is a proc… Read More
  • Noncompetitive AntagonistsNoncompetitive antagonists bind to an alternative site than the agonist to prevent the agonist from binding the receptor. Noncompetitive antagonist bi… Read More

0 comments:

Post a Comment